[1]郭 能,陈 英.哌拉西林联合阿奇霉素治疗肺炎支原体性肺炎的临床疗效及安全性[J].医学信息,2025,38(07):109-112.[doi:10.3969/j.issn.1006-1959.2025.07.020]
　GUO Neng,CHEN Ying.Clinical Efficacy and Safety of Piperacillin Combined with Azithromycin in the Treatment of Mycoplasma Pneumoniae Pneumonia[J].Journal of Medical Information,2025,38(07):109-112.[doi:10.3969/j.issn.1006-1959.2025.07.020]
点击复制

哌拉西林联合阿奇霉素治疗肺炎支原体性肺炎的临床疗效及安全性()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
38卷
期数:
2025年07期
页码:
109-112
栏目:
论著
出版日期:
2025-04-01

文章信息/Info

Title:
Clinical Efficacy and Safety of Piperacillin Combined with Azithromycin in the Treatment of Mycoplasma Pneumoniae Pneumonia
文章编号:
1006-1959（2025）07-0109-04
作者:
郭 能; 陈 英
峡江县人民医院儿科，江西 峡江 331409
Author(s):
GUO Neng;  CHEN Ying
Department of Pediatrics, Xiajiang County People’s Hospital, Xiajiang 331409, Jiangxi, China
关键词:
哌拉西林; 阿奇霉素; 支原体性肺炎; 炎性因子水平
Keywords:
Piperacillin;  Azithromycin;  Mycoplasma pneumonia;  Inflammatory factor levels
分类号:
R725.6
DOI:
10.3969/j.issn.1006-1959.2025.07.020
文献标志码:
A
摘要:
目的 探讨哌拉西林联合阿奇霉素治疗肺炎支原体性肺炎的临床疗效及安全性。方法 按照随机数字表法将2021年1月-2023年10月峡江县人民医院接诊的支原体性肺炎患儿60例分为对照组和研究组，每组30例。对照组应用阿奇霉素干混悬剂治疗，研究组在对照组基础上采用哌拉西林钠他唑巴坦钠治疗。比较两组临床疗效、临床症状（发热、气促、咳嗽、肺部啰音）评分、血清炎性因子水平[C反应蛋白（CRP）、降钙素原（PCT）、白细胞介素-6（IL-6）、白细胞介素-1（IL-1）]、不良反应（恶心、发烧、呕吐、腹痛）发生率。结果 研究组治疗总有效率为96.67%，对照组治疗总有效率为73.33%，组间比较，差异有统计学意义（P＜0.05）；与对照组比较，研究组治疗后临床症状评分、血清炎性因子水平（CRP、PCT、IL-6、IL-1）降低，差异有统计学意义（P＜0.05）；研究组不良反应发生率为23.33%，对照组不良反应发生率为20.00%，组间比较，差异无统计学意义（P＞0.05）。结论 哌拉西林联合阿奇霉素治疗肺炎支原体性肺炎的临床疗效确切，可以促进患者临床症状改善，缓解机体炎症反应，降低不良反应发生风险，具有较高的安全性。
Abstract:
Objective To investigate the clinical efficacy and safety of piperacillin combined with azithromycin in the treatment of mycoplasma pneumoniae pneumonia. Methods According to the random number table method, 60 children with mycoplasma pneumonia admitted to Xiajiang County People’s Hospital from January 2021 to October 2023 were divided into control group and study group, with 30 children in each group. The control group was treated with azithromycin dry suspension, and the study group was treated with piperacillin sodium and tazobactam sodium on the basis of the control group. The clinical efficacy, clinical symptoms (fever, shortness of breath, cough, pulmonary rales) scores, serum inflammatory factor levels [C-reactive protein (CRP), procalcitonin (PCT), interleukin-6 (IL-6), interleukin-1 (IL-1)], and incidence of adverse reactions (nausea, fever, vomiting, abdominal pain) were compared between the two groups. Results The total effective rate of the study group was 96.67%, and the total effective rate of the control group was 73.33%, the difference between the two groups was statistically significant (P<0.05). Compared with the control group, the clinical symptom score and serum inflammatory factor levels (CRP, PCT, IL-6, IL-1) in the study group decreased after treatment, and the difference were statistically significant (P<0.05). The incidence of adverse reactions in the study group was 23.33%, and the incidence of adverse reactions in the control group was 20.00%, but there was no significant difference between the two groups (P>0.05). Conclusion Piperacillin combined with azithromycin has a definite clinical effect in the treatment of mycoplasma pneumoniae pneumonia, which can promote the improvement of clinical symptoms, relieve the body’s inflammatory response, reduce the risk of adverse reactions, and has high safety.

参考文献/References:

[1]唐云丽,康丽,雷超兰,等.布地奈德雾化吸入剂治疗肺炎支原体肺炎患儿的临床研究[J].中国临床药理学杂志,2023,39(3):332-335.[2]拓玉芬,马娇.阿奇霉素治疗小儿支原体肺炎临床疗效及对血小板、D二聚体影响分析[J].贵州医药,2023,47(2):230-231.[3]许士梅,张晓蔚,韩新光,等.支气管镜治疗大叶性支原体肺炎的时机与疗效研究[J].重庆医学,2023,52(10):1464-1468.[4]孔霞,郦银芳,张莉,等.丙酸氟替卡松联合红霉素治疗肺炎支原体感染伴喘息疗效观察[J].药学与临床研究,2023,31(1):85-88.[5]李天超,展效文,徐亚利,等.阿奇霉素联合甲泼尼龙治疗儿童重症肺炎支原体肺炎疗效观察[J].新乡医学院学报,2023,40(6):543-547.[6]储芳芳,梁磊,许崇玉.早期应用软式支气管镜治疗对小儿肺炎支原体肺炎合并支气管黏液栓的疗效[J].临床和实验医学杂志,2023,22(4):410-414.[7]王倩云,王海立,邵贤丽,等.难治性肺炎支原体肺炎患儿需行支气管镜辅助治疗风险预测模型的构建与验证[J].中国妇幼健康研究,2023,34(5):82-88.[8]王成效,田春霞.低分子肝素辅助治疗D-二聚体升高的重症肺炎支原体肺炎患儿的临床疗效观察[J].贵州医药,2023,47(2):248-249.[9]李敏,邵换璋.热毒宁注射液联合哌拉西林钠他唑巴坦钠治疗重症肺炎的临床研究[J].现代药物与临床,2022,37(12):2790-2794.[10]亓玲,魏丽,李静.哌拉西林钠他唑巴坦钠联合布地奈德雾化吸入治疗新生儿肺炎的临床研究[J].中国临床药理学杂志,2023,39(14):1979-1982.[11]胡妮娜,戴文涛,刘娴.痰热清注射液联合哌拉西林钠他唑巴坦钠辅助心理干预治疗急性肺炎临床研究[J].新中医,2020,52(5):65-67.[12]赵晓飞,王雪倩,张培芳.不同给药方案治疗医院获得性肺炎患者的疗效和成本分析及对血清SPA水平的影响[J].东南国防医药,2022,24(6):590-595.[13]周艳红,吴梅,张宁.哌拉西林他唑巴坦与头孢唑肟治疗医院获得性肺炎的有效性和药物经济学研究[J].中国医药,2022,17(1):50-53.[14]李珊珊,张云沛,刘晓锡.加味麻杏石甘汤联合阿奇霉素序贯疗法治疗小儿支原体肺炎患儿的疗效及对血清炎症因子、氧化应激反应的影响[J].临床和实验医学杂志,2023,22(8):870-875.[15]何林,袁艺,曹玲,等.阿奇霉素疗程与肺炎支原体肺炎患儿体内药物浓度的相关性研究[J].中国医刊,2023,58(2):206-210.[16]梁文婷,吴小红,颜海峰,等.百令胶囊联合阿奇霉素治疗小儿支原体肺炎疗效及对血清sPD-1、CYTL1水平的影响[J].疑难病杂志,2023,22(2):124-131.[17]张丽,尹莉,商树芹.布地奈德联合阿奇霉素治疗小儿难治性支原体肺炎的疗效及其对患儿免疫功能的影响[J].川北医学院学报,2023,38(4):496-499,504.[18]罗洪霞,李波,李洪刚,等.双歧杆菌三联活菌肠溶胶囊联合阿奇霉素序贯疗法治疗对肺炎支原体肺炎腹泻患儿胃肠炎症的调节作用[J].中南医学科学杂志,2023,51(1):139-141.[19]严慧,王兰英,吴小磊,等.泼尼松联合阿奇霉素序贯疗法治疗儿童重症肺炎支原体肺炎的疗效及对血清TLR4/MyD88/NF-κB信号通路相关蛋白和下游炎性因子水平的影响[J].中国临床新医学,2023,16(5):474-478.[20]赵琦,袁红亮,李珊珊.加味麻杏石甘汤联合阿奇霉素治疗小儿支原体肺炎疗效及对机体细胞免疫应答、血清Fbg和G-CSF水平的影响[J].现代中西医结合杂志,2022,31(10):1399-1402.

相似文献/References:

[1]赵俊芝,赵永强,梁 曼.甲泼尼龙联合阿奇霉素治疗难治性支原体肺炎患儿的 临床效果分析[J].医学信息,2018,31(07):131.[doi:10.3969/j.issn.1006-1959.2018.07.044]
　ZHAO Jun-zhi,ZHAO Yong-qiang,LIANG Man.Analysis of the Clinical Effect of Methylprednisolone Combined with Azithromycin in Treatment of Children with Refractory Mycoplasma Pneumonia[J].Journal of Medical Information,2018,31(07):131.[doi:10.3969/j.issn.1006-1959.2018.07.044]
[2]冯瑞丰.阿奇霉素治疗急性细菌性下呼吸道感染的 有效性和安全性评价[J].医学信息,2019,32(11):152.[doi:10.3969/j.issn.1006-1959.2019.11.045]
　FENG Rui-feng.Evaluation of the Efficacy and Safety of Azithromycin in the Treatment of Acute Bacterial Lower Respiratory Tract Infections[J].Journal of Medical Information,2019,32(07):152.[doi:10.3969/j.issn.1006-1959.2019.11.045]
[3]陈艳丽.甲泼尼龙联合阿奇霉素治疗小儿难治性支原体肺炎的疗效与安全性的Meta分析[J].医学信息,2020,33(06):96.[doi:10.3969/j.issn.1006-1959.2020.06.028]
　CHEN Yan-li.Meta-analysis of the Efficacy and Safety of Methylprednisolone Combined with Azithromycin in the Treatment of Refractory Mycoplasmal Pneumonia in Children[J].Journal of Medical Information,2020,33(07):96.[doi:10.3969/j.issn.1006-1959.2020.06.028]
[4]刘金虹.阿奇霉素用于儿科抗感染的不良反应分析[J].医学信息,2020,33(16):161.[doi:10.3969/j.issn.1006-1959.2020.16.052]
　LIU Jin-hong.Analysis of Adverse Reaction of Azithromycin in Pediatric Anti-infection[J].Journal of Medical Information,2020,33(07):161.[doi:10.3969/j.issn.1006-1959.2020.16.052]
[5]张舒扬.阿奇霉素联合头孢地嗪对急性细菌性痢疾患儿白细胞计数及C-反应蛋白水平的影响[J].医学信息,2022,35(06):165.[doi:10.3969/j.issn.1006-1959.2022.06.043]
　ZHANG Shu-yang.Effect of Azithromycin Combined with Cefodizime on White Blood Cell Count and C-reactive Protein Level in Children with Acute Bacillary Dysentery[J].Journal of Medical Information,2022,35(07):165.[doi:10.3969/j.issn.1006-1959.2022.06.043]
[6]吴建伟.阿奇霉素联合头孢类药物在慢性阻塞性肺疾病急性加重期抗感染治疗中的疗效[J].医学信息,2022,35(13):127.[doi:10.3969/j.issn.1006-1959.2022.13.029]
　WU Jian-wei.Effect of Azithromycin Combined with Cephalosporins in Anti-infection Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2022,35(07):127.[doi:10.3969/j.issn.1006-1959.2022.13.029]
[7]温 鑫,邓 春.盐酸氨溴索辅佐阿奇霉素治疗儿童肺炎支原体肺炎的疗效评价[J].医学信息,2023,36(06):147.[doi:10.3969/j.issn.1006-1959.2023.06.032]
　WEN Xin,DENG Chun.Efficacy Evaluation of Ambroxol Hydrochloride Combined with Azithromycin in the Treatment of Mycoplasma Pneumoniae Pneumonia in Children[J].Journal of Medical Information,2023,36(07):147.[doi:10.3969/j.issn.1006-1959.2023.06.032]
[8]郭志丽,刘改莲,贺 蓉.阿奇霉素、氨溴特罗联合肺力咳合剂对支原体感染患儿血常规及CRP水平的影响[J].医学信息,2023,36(09):124.[doi:10.3969/j.issn.1006-1959.2023.09.025]
　GUO Zhi-li,LIU Gai-lian,HE Rong.Effect of Azithromycin, Ambroxol Combined with Feilike Mixture on Blood Routine and CRP Level in Children with Mycoplasma Infection[J].Journal of Medical Information,2023,36(07):124.[doi:10.3969/j.issn.1006-1959.2023.09.025]
[9]皮祖骞.连花清瘟颗粒联合阿奇霉素治疗小儿肺炎支原体肺炎的临床疗效[J].医学信息,2023,36(10):154.[doi:10.3969/j.issn.1006-1959.2023.10.034]
　PI Zu-qian.Clinical Effect of Lianhua Qingwen Granules Combined with Azithromycin in the Treatment of Mycoplasma Pneumoniae Pneumonia in Children[J].Journal of Medical Information,2023,36(07):154.[doi:10.3969/j.issn.1006-1959.2023.10.034]
[10]章云云.美洛西林联合阿奇霉素治疗小儿肺炎链球菌肺炎的临床效果[J].医学信息,2023,36(13):131.[doi:10.3969/j.issn.1006-1959.2023.13.027]
　ZHANG Yun-yun.Clinical Effect of Mezlocillin Combined with Azithromycin in the Treatment of Children with Streptococcus Pneumoniae Pneumonia[J].Journal of Medical Information,2023,36(07):131.[doi:10.3969/j.issn.1006-1959.2023.13.027]

更新日期/Last Update: 1900-01-01